| Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors M Vadacca, D Margiotta, A Rigon, F Cacciapaglia, G Coppolino, ... The Journal of rheumatology 36 (2), 295-297, 2009 | 132 | 2009 |
| Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups C Ferri, F Ursini, L Gragnani, V Raimondo, D Giuggioli, R Foti, M Caminiti, ... Journal of autoimmunity 125, 102744, 2021 | 113 | 2021 |
| Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance EM Zardi, V Uwechie, D Caccavo, NM Pellegrino, F Cacciapaglia, ... Journal of gastroenterology 44, 76-83, 2009 | 95 | 2009 |
| Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus M Vadacca, EM Zardi, D Margiotta, A Rigon, F Cacciapaglia, L Arcarese, ... Internal and emergency medicine 8, 705-712, 2013 | 83 | 2013 |
| Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients F Cacciapaglia, EM Zardi, G Coppolino, F Buzzulini, D Margiotta, ... Lupus 18 (3), 249-256, 2009 | 76 | 2009 |
| Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study) BM Colombo, F Cacciapaglia, M Puntoni, G Murdaca, E Rossi, ... Autoimmunity reviews 8 (4), 309-315, 2009 | 76 | 2009 |
| Cardiovascular safety of anti-TNF-alpha therapies: facts and unsettled issues F Cacciapaglia, L Navarini, P Menna, E Salvatorelli, G Minotti, A Afeltra Autoimmunity reviews 10 (10), 631-635, 2011 | 58 | 2011 |
| Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs EM Zardi, DM Zardi, F Cacciapaglia, A Dobrina, A Amoroso, A Picardi, ... International immunopharmacology 5 (3), 437-459, 2005 | 55 | 2005 |
| Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis F Iannone, L Santo, MG Anelli, R Bucci, A Semeraro, L Quarta, ... Seminars in arthritis and rheumatism 47 (1), 108-114, 2017 | 44 | 2017 |
| Alexithymia and neuroendocrine‐immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF‐α levels R Bruni, FM Serino, S Galluzzo, G Coppolino, F Cacciapaglia, M Vadacca, ... Annals of the New York Academy of Sciences 1069 (1), 208-211, 2006 | 44 | 2006 |
| Inflammation and iron metabolism in adult patients with epilepsy: does a link exist? M Tombini, R Squitti, F Cacciapaglia, M Ventriglia, G Assenza, ... Epilepsy Research 107 (3), 244-252, 2013 | 41 | 2013 |
| Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long‐term tocilizumab treatment F Cacciapaglia, MG Anelli, A Rinaldi, M Fornaro, G Lopalco, C Scioscia, ... Mediators of inflammation 2018 (1), 2453265, 2018 | 39 | 2018 |
| Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases F Ursini, P Ruscitti, V Raimondo, R De Angelis, F Cacciapaglia, E Pigatto, ... Annals of the Rheumatic Diseases 81 (3), 440-441, 2022 | 35 | 2022 |
| Lipid profile of rheumatoid arthritis patients treated with anti‐tumor necrosis factor‐alpha drugs changes according to disease activity and predicts clinical response F Cacciapaglia, MG Anelli, A Rinaldi, L Serafino, M Covelli, C Scioscia, ... Drug development research 75, S77-S80, 2014 | 33 | 2014 |
| Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis F Iannone, M Nivuori, M Fornaro, V Venerito, F Cacciapaglia, G Lopalco Rheumatology 59 (7), 1599-1606, 2020 | 32 | 2020 |
| The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement A Amoroso, F Cacciapaglia, S De Castro, A Battagliese, G Coppolino, ... Clinical and experimental rheumatology 24 (3), 287, 2006 | 29 | 2006 |
| Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors V Venerito, P Stefanizzi, M Fornaro, F Cacciapaglia, S Tafuri, S Perniola, ... RMD open 8 (1), e001847, 2022 | 25 | 2022 |
| Alexithymia and immunoendocrine parameters in patients affected by systemic lupus erythematosus and rheumatoid arthritis M Vadacca, R Bruni, F Caccipaglia, F Serino, L Arcarese, F Buzzulini, ... Reumatismo 60 (1), 50-56, 2008 | 24 | 2008 |
| Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse MI Hawa, MG Valorani, LR Buckley, PE Beales, A Afeltra, F Cacciapaglia, ... Hormone and metabolic research 36 (09), 620-624, 2004 | 24 | 2004 |
| Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum C Ferri, D Giuggioli, S Guiducci, F Lumetti, G Bajocchi, L Magnani, ... Clinical and experimental rheumatology 38, S40-S47, 2020 | 23 | 2020 |
